| Primary |
| Cancer Pain |
27.5% |
| Drug Use For Unknown Indication |
19.8% |
| Pain |
13.9% |
| Insomnia |
4.2% |
| Product Used For Unknown Indication |
4.2% |
| Prophylaxis |
4.2% |
| Constipation |
3.9% |
| Nausea |
2.6% |
| Back Pain |
2.1% |
| Diabetes Mellitus |
2.0% |
| Metastases To Bone |
2.0% |
| Chemotherapy |
1.9% |
| Anorexia |
1.7% |
| Asthma |
1.7% |
| Delirium |
1.7% |
| Intervertebral Disc Protrusion |
1.7% |
| Chest Pain |
1.4% |
| Metastases To Central Nervous System |
1.3% |
| Dementia Alzheimer's Type |
1.1% |
| Hypertension |
1.1% |
|
| Wrong Technique In Drug Usage Process |
28.5% |
| Drug Prescribing Error |
10.0% |
| Somnolence |
10.0% |
| Delirium |
8.0% |
| Vomiting |
5.5% |
| Renal Impairment |
5.0% |
| Nausea |
4.0% |
| Pain |
3.5% |
| Respiratory Depression |
3.5% |
| Drug Interaction |
2.5% |
| Treatment Noncompliance |
2.5% |
| Withdrawal Syndrome |
2.5% |
| Convulsion |
2.0% |
| Drug Eruption |
2.0% |
| Hallucination |
2.0% |
| Hepatic Function Abnormal |
2.0% |
| Liver Disorder |
2.0% |
| Compulsions |
1.5% |
| Deafness |
1.5% |
| Drug Effect Increased |
1.5% |
|
| Secondary |
| Pain |
24.4% |
| Cancer Pain |
18.3% |
| Chest Pain |
5.9% |
| Intervertebral Disc Protrusion |
5.0% |
| Prophylaxis |
4.9% |
| Metastases To Bone |
4.5% |
| Nausea |
4.4% |
| Drug Use For Unknown Indication |
4.2% |
| Anxiety |
4.0% |
| Abdominal Pain Lower |
3.9% |
| Constipation |
3.3% |
| Insomnia |
2.9% |
| Anorexia |
2.8% |
| Gastritis |
2.5% |
| Haemorrhoids |
2.0% |
| Chemotherapy |
1.7% |
| Dementia Alzheimer's Type |
1.4% |
| Metastases To Central Nervous System |
1.4% |
| Autoimmune Thyroiditis |
1.2% |
| Cerebral Arteriosclerosis |
1.2% |
|
| Somnolence |
28.9% |
| Wrong Technique In Drug Usage Process |
20.5% |
| Vomiting |
11.0% |
| Large Intestine Perforation |
3.8% |
| Lung Cancer Metastatic |
3.8% |
| Withdrawal Syndrome |
3.8% |
| Renal Impairment |
3.4% |
| Liver Disorder |
3.0% |
| Delirium |
2.7% |
| Respiratory Depression |
2.7% |
| Restlessness |
2.7% |
| Uterine Cancer |
2.3% |
| Nausea |
1.9% |
| Treatment Noncompliance |
1.9% |
| Pain |
1.5% |
| Respiratory Failure |
1.5% |
| Drug Interaction |
1.1% |
| Hallucination |
1.1% |
| Inadequate Analgesia |
1.1% |
| Rash Generalised |
1.1% |
|
| Concomitant |
| Cancer Pain |
16.9% |
| Prophylaxis |
15.1% |
| Multiple Myeloma |
10.0% |
| Constipation |
7.0% |
| Product Used For Unknown Indication |
5.8% |
| Drug Use For Unknown Indication |
5.2% |
| Pain |
5.1% |
| Insomnia |
4.4% |
| Nausea |
4.0% |
| Hypertension |
3.6% |
| Pleural Mesothelioma Malignant |
3.1% |
| Pain Management |
2.7% |
| Gastritis |
2.5% |
| Renal Cell Carcinoma |
2.4% |
| Hepatic Neoplasm Malignant |
2.2% |
| Diabetes Mellitus |
2.1% |
| Prostate Cancer Stage Iv |
2.1% |
| Acquired Immunodeficiency Syndrome |
2.0% |
| Metastases To Bone |
2.0% |
| Breast Cancer |
1.9% |
|
| White Blood Cell Count Decreased |
20.2% |
| Vomiting |
12.0% |
| Interstitial Lung Disease |
7.8% |
| Pneumonia |
5.4% |
| Pyrexia |
5.4% |
| Renal Impairment |
5.1% |
| Sepsis |
4.8% |
| Off Label Use |
4.2% |
| Malignant Neoplasm Progression |
3.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.6% |
| Respiratory Arrest |
3.6% |
| Renal Cell Carcinoma |
3.3% |
| Tumour Lysis Syndrome |
3.3% |
| Platelet Count Decreased |
3.0% |
| Thrombocytopenia |
3.0% |
| Malaise |
2.4% |
| Prostate Cancer |
2.4% |
| Stomatitis |
2.4% |
| Disease Progression |
2.1% |
| Liver Disorder |
2.1% |
|
| Interacting |
| Arthralgia |
50.0% |
| Rheumatoid Arthritis |
50.0% |
|
|
